In Silico Mining of Natural Products Atlas (NPAtlas) Database for Identifying Effective Bcl-2 Inhibitors: Molecular Docking, Molecular Dynamics, and Pharmacokinetics Characteristics
Molecules · 2023
DOI: 10.3390/molecules28020783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Nahlah Makki Almansour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Hafr Al Batin, Hafr Al Batin 1803, Saudi Arabia. Hauptthemen laut MEDLINE: Biological Products, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Hafr Al-Batin, institutional fund projects.
Abstract (Originalsprache)
The Bcl-2 protein has a vital function in controlling the programmed cell doom of mitochondria. If programmed cell death signals are obstructed, an imbalance between cell survival and death will occur, which is a significant reason for cancer. Therefore, the Bcl-2 protein was identified as a possible therapeutic target for carcinoma treatment. Herein, the Natural Products Atlas (NPAtlas) compounds were virtually screened, seeking potent inhibitors towards the Bcl-2 protein. The performance of AutoDock Vina software to predict the docking score and pose of the investigated compounds was first validated according to the available experimental data. Based on the validated AutoDock Vina parameters, the NPAtlas database was filtered against the Bcl-2 protein. The natural compounds with docking scores less than that of the venetoclax (calc. −10.6 kcal/mol) were submitted to MD simulations, followed by MM-GBSA binding energy calculations. According to MM-GBSA//200 ns MD simulations, saquayamycin F (NPA002200) demonstrated promising binding affinity with a ΔGbinding value of −53.9 kcal/mol towards the Bcl-2 protein when compared to venetoclax (ΔGbinding = −50.6 kcal/mol). The energetical and structural analyses showed a great constancy of the saquayamycin F inside the Bcl-2 protein active site. Moreover, the ADMET and drug-likeness features of the saquayamycin F were anticipated, indicating its good oral bioavailability. According to in silico computations, saquayamycin F is proposed to be used as a therapeutic agent against the wild-type Bcl-2 protein and warrants further experimental assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, University of Hafr Al Batin, Hafr Al Batin 1803, Saudi Arabia.
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
- Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt.
- School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa.
ORCID-Profile: Nahlah Makki Almansour, Khaled S Allemailem, Ekram Ismail Fagiree Ismail, Mahmoud A A Ibrahim
Förderung
- University of Hafr Al-Batin
- institutional fund projects
Zitieren
APA
Almansour, N. M., Allemailem, K. S., Abd El Aty, A. A., Ismail, E. I. F., & Ibrahim, M. A. A. (2023). In Silico Mining of Natural Products Atlas (NPAtlas) Database for Identifying Effective Bcl-2 Inhibitors: Molecular Docking, Molecular Dynamics, and Pharmacokinetics Characteristics. Molecules. https://doi.org/10.3390/molecules28020783
Vancouver
Almansour NM, Allemailem KS, Abd El Aty AA, Ismail EIF, Ibrahim MAA. In Silico Mining of Natural Products Atlas (NPAtlas) Database for Identifying Effective Bcl-2 Inhibitors: Molecular Docking, Molecular Dynamics, and Pharmacokinetics Characteristics. Molecules. 2023. doi:10.3390/molecules28020783
BibTeX
@article{Almansour2023,
author = {Almansour, Nahlah Makki and Allemailem, Khaled S and Abd El Aty, Abeer Abas and Ismail, Ekram Ismail Fagiree and Ibrahim, Mahmoud A A},
title = {In Silico Mining of Natural Products Atlas (NPAtlas) Database for Identifying Effective Bcl-2 Inhibitors: Molecular Docking, Molecular Dynamics, and Pharmacokinetics Characteristics},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28020783}
}
EUVIMED